Clevidipine-d7
Clevidipine-d7 is the deuterium labeled Clevidipine. Clevidipine is a short-acting dihydropyridine calcium channel antagonist (IC50= 7.1 nM, V(H) = -40 mV ) under development for treatment of perioperative hypertension.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2747918-66-5
- Fòrmula: C21H16D7Cl2NO6
- Peso molecular:463.36
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
-
HY-150084
(±)14,15-Epoxyeicosatrienoic acidProliferation Inducer -
HY-N0455AS2
L-Arginine-d7 hydrochlorideStable Isotope -
HY-N2403
DihydrolycorineProtein Synthesis Inhibitor -
HY-B1114
GliquidoneAnti-Diabetic Drug -
HY-116429
Maresin 1Ca2+ Stimulator -
HY-122425
Nylidrin -
HY-34350
2-(Aminomethyl)phenolAntioxidant -
HY-B0150S
Nicotinamide-d4Stable Isotope -
HY-12721S
Clonidine-d4 hydrochlorideStable Isotope -
HY-B1486AS
Oxprenolol-d7Stable Isotope -
HY-A0270S
Diphenadol-d10Stable Isotope -
HY-B1114R
Gliquidone (Standard)Anti-Diabetic Drug
Ver todos los productos específicos de isoformas Calcium Channel
More
Actividad biológica
Descripciòn
In Vitro
Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Aplicación
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
No. CAS 2747918-66-5
-
Unlabeled CAS 167221-71-8
-
Peso molecular 463.36
-
Fòrmula C21H16D7Cl2NO6
-
SMILES
ClC1=CC=CC(C2C(C(OCOC(C(C(C([2H])([2H])[2H])([2H])[2H])([2H])[2H])=O)=O)=C(NC(C)=C2C(OC)=O)C)=C1Cl
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. [Content Brief]
[2]. Yi X, Vivien B, Lynch C 3rd. Clevidipine blockade of L-type Ca2+ currents: steady-state and kinetic electrophysiological studies in guinea pigventricular myocytes. [Content Brief]
[3]. Huraux C, Makita T, Szlam F, The vasodilator effects of clevidipine on human internal mammary artery. Anesth Analg. 1997 Nov;85(5):1000-4. [Content Brief]
[4]. Ericsson H, et al. In vitro hydrolysis rate and protein binding of clevidipine, a new ultrashort-acting calcium antagonist metabolised by esterases, in different animal species and man. Eur J Pharm Sci. 1999 Apr;8(1):29-37. [Content Brief]
[5]. Ericsson H, et al. Pharmacokinetics of new calcium channel antagonist clevidipine in the rat, rabbit, and dog and pharmacokinetic/pharmacodynamic relationship in anesthetized dogs. Drug Metab Dispos. 1999 May;27(5):558-64. [Content Brief]
[6]. Schwieler JH, et al. Circulatory effects and pharmacology of clevidipine, a novel ultra short acting and vascular selective calcium antagonist, in hypertensive humans. J Cardiovasc Pharmacol. 1999 Aug;34(2):268-74. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Clevidipine-d7 Related Classifications
HY-17436S1 Related Classifications
Powered by Bioz